Potential Link Between Regular Opioid Use and Increased Dementia Risk
New research associates regular opioid consumption with a higher risk of dementia and brain volume reduction, emphasizing cautious opioid prescribing for chronic pain management.
Recent research published in Alzheimer's & Dementia reveals a significant association between consistent opioid use and a heightened risk of developing dementia, especially vascular dementia. Led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology and collaborating with experts from Massachusetts Veterans Home and the University of Pennsylvania, the study highlights critical insights into how opioids may influence cognitive health.
Chronic non-cancer pain (CNCP), a condition persisting for over three months unrelated to cancer, saw widespread opioid prescriptions starting in the mid-1990s. This increase has raised concerns over dependence, misuse, and potential neurological impacts. Existing evidence suggests that opioids can alter the brain's endogenous opioid system and impair regions such as the hippocampus, which are vital for cognitive function.
The study analyzed data from 197,673 UK Biobank participants aged between 37 and 73 years over an average follow-up period of nearly 14 years. Employing advanced statistical models to control for confounding factors, researchers found that individuals who regularly used opioids faced a 20% higher overall risk of developing dementia compared to non-opioid analgesic users. Those on high-potency opioids faced an even greater risk, exceeding 70%. Conversely, individuals taking non-opioid painkillers showed dementia risk comparable to those not using opioids.
Neuroimaging assessments further revealed that regular, strong opioid use was associated with reductions in total brain volume, white matter, and hippocampal size—regions crucial for memory and cognition. Additionally, regular opioid use was linked to decreased fluid intelligence, although no significant decline was observed in prospective memory.
These findings underscore the importance of evaluating opioid potency and cumulative exposure when considering risks related to cognitive decline. The research underscores the necessity for cautious opioid prescribing, especially for long-term pain management, to mitigate potential adverse effects on brain health.
Source: https://medicalxpress.com/news/2025-07-regular-opioid-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Childhood Exposure to Air Pollution May Impact Adolescent Health
New research reveals that childhood exposure to air pollution is linked to poorer health outcomes in late adolescence, highlighting environmental health disparities and the importance of pollution reduction policies.
Critical Gaps in Genetic Cancer Risk Testing Revealed by Recent Study
A study uncovers significant gaps in genetic testing for Lynch syndrome among womb cancer patients, highlighting the need for improved screening processes to prevent future cancers and protect families.
Study Shows Wearable Devices Vary in Accuracy for Fitness Metrics
A recent study examines the accuracy of wearable fitness devices like Apple Watch, highlighting their strengths in tracking heart rate and steps but cautioning about energy expenditure errors. Learn how these devices can support your health journey while recognizing their limitations.
Cannabis Use Linked to Reduced Risk of Postoperative Eyesight Complication
New research suggests cannabis use may lower the risk of complications following retinal detachment surgery. Learn more about this emerging connection in ophthalmology research.